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ku.kanazawa-u.ac.jp (H. Sato).Fibronectin (FN) matrix assembly is an essential process in normal vertebrate development, which is
frequently lost in tumor cells. Here we show that membrane-type 1 matrix metalloproteinase (MT1-
MMP) regulates FN matrix assembly. MT1-MMP knockdown induced FN assembly in breast carci-
noma cells. Ectopic expression of MT1-MMP reduced speciﬁcally the assembled FN matrix level
without affecting whole FN production in ﬁbroblasts. Treatment of ﬁbrosarcoma HT1080 cells with
dexamethasone (DEX) enhanced FN synthesis, resulting in short ﬁbrils but not dense matrix forma-
tion. Combined treatment of DEX and MT1-MMP inhibitor accelerated FN matrix assembly, which
mediated cellular adhesion and reduced cell migration and invasion. These results indicate that
MT1-MMP stimulates cell migration and invasion by negatively regulating FN assembly.
Structured summary of protein interactions:
FN and Integrin Beta 1 colocalize by ﬂuorescence microscopy (View interaction)
FN and Paxillin colocalize by ﬂuorescence microscopy (View interaction)
 2011 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
The extracellular matrix (ECM) is a complex network of struc-
tural and functional proteins that not only provides cell anchorage
but also regulates cell proliferation, migration, and differentiation.
Its remodeling can be regulated by synthesis, contraction, and deg-
radation. Changes in ECM composition, concentration, and presen-
tation modulate cellular behavior through interactions mediated
by cell surface receptor integrins [1,2]. Tumor cells often have
abnormal interactions with ECM due to alternations in integrins,
ECM ligands, ECM degrading enzymes, and the cytoskeleton.
Oncogenically transformed cells are known to show decreased
synthesis and increased degradation of ﬁbronectin (FN), resulting
in a decrease of FN matrix [1,2].
FN is an ECM glycoprotein that plays a role in cell adhesion and
migration during embryonic development, wound repair, andchemical Societies. Published by E
extracellular matrix; DEX,
le’s medium; DOC, sodium
rix metalloproteinase; PBS,
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jp (T. Takino), vhsato@kenro-tumor progression. FN is found as two general forms; plasma FN
(pFN), a soluble form synthesized by hepatocytes, and cellular FN
(cFN), which is locally expressed by many other cell types in vari-
ous tissues. There are several structural differences between pFN
and cFN. Two type III modules (EDA and EDB) are missing com-
pletely in pFN. Both forms can be assembled into a ﬁbrillar matrix.
However, skin wound repair is observed in adult mice with a con-
ditional knockout of pFN, suggesting that cFN possesses an impor-
tant role in physiological FN assembly [1–5]. Mesenchymal cells
secrete compact and inactive FN dimers. Integrin-bound FN is ﬁrst
diffusely localized at the cell surfaces. As a dimeric ligand, FN
induces receptor clustering by binding two integrins, which leads
conformational changes and activation to promote intermolecular
interactions with other FN dimers. Then, cells initially form short
ﬁbrils on cell surface, which requires FN-integrin clustering and
continuous binding of FN to create a high local concentration of
FN. These newly assembled FN are discriminated as a detergent
deoxycholate (DOC)-soluble fraction. With increasing time, FN
continues to accumulate on cell surface, and FN-bound integrins
move and aggregate to form a dense DOC-insoluble matrix. This
process requires interaction between integrin cytoplasmic domain
and actin-associated proteins, which is facilitated by the increased
cytoskeletal tension generated by cadherin adhesion [6].lsevier B.V. All rights reserved.
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cell–cell adhesions, facilitating detachment of cells from sur-
rounding tissues. Membrane-type 1 matrix metalloproteinase
(MT1-MMP) has been implicated in tumor progression [7,8]. It
was originally identiﬁed as a tumor-speciﬁc activator of MMP-
2 [9] and is now known to activate MMP-13 and degrade a wide
range of ECM components, including type I, II, III collagen, lam-
inins, and FN. This enzyme also processes and interacts with
membrane proteins such as integrins [10], CD44 [11], and synd-
ecan-1 [12], all of which regulates tumor cell migration and
invasion. Recent studies have shown that MT1-MMP functions
as a collagenolytic growth factor in three-dimensional ECM
[13]. MT1-MMP inhibition suppresses tumor cell invasion both
in vitro and in vivo [7–9].
Although ﬁbrillar assembly is regulated by synthesis and
binding of FN to integrins and cytoskeletal tension, the effect of
FN proteolysis in this process is not understood well. In this study,
we examined the role of MT1-MMP in FN matrix assembly and
demonstrated that MT1-MMP preferentially digests assembled
FN which governs cell motility.2. Materials and methods
2.1. Cell culture and reagents
Human ﬁbrosarcoma HT1080 cells were obtained from the
Health Science Research Bank (Osaka, Japan). Human breast
carcinoma MDA-MB-231 cells were gifted by Dr. E. W. Thompson
(University of Melbourne, Australia). Rat 1 ﬁbroblasts were
provided by Dr. K. Yoshioka (Kanazawa University, Japan). Cells
were maintained in Dulbecco’s modiﬁed Eagle’s medium (DMEM)
supplemented with 10% FBS. A synthetic MMP inhibitor BB94
(batimastat) was a kind gift from the Kotobuki Pharmaceutical
(Nagano, Japan). BB94 contains a peptide backbone that binds to
the MMP and a hydroxamic acid group that binds to the catalyti-
cally active zinc atom and thereby inhibiting a broad spectrum of
MMPs. An anti-MT1-MMP antibody was a gift from Fuji ﬁne
chemicals (Toyama, Japan). The immunological reagents used were
anti-FN, anti-a-tubulin, and anti-FLAG antibodies (Sigma–Aldrich);
anti-FN and anti-paxillin antibodies (BD Biosciences); an anti-inte-
grin b1 antibody (Immunotech); Rhodamine-labeled phalloidin and
DAPI (Molecular Probes). Type I collagen was purchased from Nitta
Gelatin (Osaka, Japan). Cells were cultured in collagen gel matrix,
as described previously [14].
2.2. Expression plasmids and transfection
Constructions of the cDNA expression vector for FLAG-tagged
MT1-MMP and full-length cFN were described previously [14,15].
Expression plasmids were transfected into cells using Lipofect-
amine 2000 (Invitrogen), according to the manufacturer’s
instructions.
2.3. Immunoﬂuorescence staining
MDA-MB-231 cells and Rat 1 ﬁbroblasts were cultured on
glass coverslips in 24-wel plates for 2 days. HT1080 cells were
seeded on glass coverslips in 24-wel plates at 3  105 cells/well
and cultured for 24 h in the presence or absence of glucocorti-
coid dexamethasone (DEX) (1 lM) and BB94 (2 lM). After treat-
ment, the cells were washed with phosphate-buffered saline
(PBS), ﬁxed with 4% paraformaldehyde, permeabilized with
0.5% Triton X-100, and reacted with indicated antibodies.
Samples were observed by confocal laser scanning microscopy
LSM510 (Carl Zeiss).2.4. Immunoblotting
Cells were washed with PBS, and homogenized in SDS lysis buf-
fer containing 10 mM Tris–HCl (pH 7.5), 100 mM NaCl, 5 mM
EDTA, 2 mM Na3VO4, 2 mM NaF, and 1% SDS. Cell lysates were cen-
trifuged at 10000g for 15 min at 15 C. Protein concentration was
determined using BCA assay (Pierce). Aliquots containing equal
amounts of total protein were separated by electrophoresis on
SDS–polyacrylamide gels and transferred onto nitrocellulose
membranes.
2.5. Gelatin zymography
Aliquots of conditioned medium were analyzed by gelatin
zymography as described previously [14,22]. After electrophoresis
with an SDS–polyacrylamide gel containing 0.1% gelatin, SDS was
replaced by Triton X-100, followed by overnight incubation in
Tris-based buffer. Gels were stained with Coomassie Brilliant Blue,
and gelatinolytic activity was detected as clear bands in the back-
ground of uniform staining.
2.6. DOC insolubility assay
After washing with ice-cold PBS, cells were lyzed (or dissolved)
in DOC buffer containing 20 mM Tris–HCl (pH 8.8), 2 mM
N-ethylmaleimide, 2 mM EDTA, 2 mM PMSF, 2% DOC, and protease
inhibitor cocktail (Nacalai tesque) on ice. Lysates were passed
through a 22 gage needle and DOC-insoluble material was
collected by centrifugation at 15000g for 30 min at 4 C. The
pellet (DOC-insoluble) was washed twice with DOC buffer, and
resolved in SDS lysis buffer. The samples from DOC-soluble
(supernatants) and DOC-insoluble fraction were subjected to
immunoblotting.
2.7. Preparation of FN matrix
Cell-derived FN matrix was prepared as described previously
[16]. Rat 1 ﬁbroblasts were cultured on chemically cross-linked
gelatin for 6 days. HT1080 cells were cultured in the presence of
both DEX and BB94 for 48 h. FN matrix was cleared from cellular
components by treatment with 0.5% Triton X-100 and 20 mM
NH4OH for 10 min. After washing twice, HT1080 cells (3  104
cells/ml) were seeded and cultured on prepared FN matrix for
24 h with or without BB94.
2.8. Wound closure assay
HT1080 cells (3  105 cells/well) were cultured for 24 h with
DEX and BB94. Then, cells were wounded by manually scratching
with a pipette tip, and incubated in 10% FBS/DMEM with or with-
out BB94. Unclosed wound areas were measured using NIH image
software.
2.9. Cell aggregation
To form spheres, HT1080 cells (2  105 cells/ml) were cultured
in suspension on Ultra Low Culture dish (Corning) with 10% FBS/
DMEM in the presence or absence of BB94 for 5 days. Spheres were
ﬁxed and stained with DAPI and anti-FN antibody.
2.10. Small interfering RNA (siRNA)-mediated protein knockdown
siRNA duplex for MT1-MMP were described previously [17,18].
siRNA for human FN (Hs_FN1_6 and _7) and negative control were
purchased from Qiagen. HT1080 cells were transfected with 20 nM
of siRNA duplexes in Opti-MEM (Gibco) using Lipofectamine RNAi
3380 T. Takino et al. / FEBS Letters 585 (2011) 3378–3384MAX (Invitrogen), according to the manufacturer’s instructions,
and were incubated for 48 h with 10% FBS/DMEM.
3. Results
3.1. MT1-MMP regulates FN assembly
To investigate whether MT1-MMP is involved in regulation of
FN assembly, MDA-MB-231 cells, which express both MT1-MMP
and FN, were transfected with siRNA for MT1-MMP and analyzed
by immunoblotting. MT1-MMP silencing increased the amount of
cell-associated FN and DOC-insoluble FN (Fig. 1A). Immunoﬂuores-
cence staining showed that MDA-MB-231 cells form short FN
ﬁbrils, which develops to FN ﬁbril network in MT1-MMP-knockd-
owned cells (Fig. 1B). In Rat 1 ﬁbroblasts that highly express FN
but not MT1-MMP, ectopic expression of MT1-MMP promoted
MMP-2 activation and attenuated the level of DOC-insoluble FN
(Fig. 1C). FN assembly was disrupted around MT1-MMP-expressingA CB
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Fig. 1. MT1-MMP regulates FN assembly. (AB) MDA-MB-231 cells were transfected with
with anti-MT1-MMP (MT1), anti-FN, or anti-tubulin antibodies. Arrowhead indicates M
described in Section 2, and immunoblotted with an anti-FN antibody (A). The transfect
antibodies (B). (CD) Rat 1 ﬁbroblasts were transfected with MT1-MMP (MT1) or empty
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stained with DAPI, anti-FN, and ant-FLAG (MT1) antibodies (D). Scale bars are 20 lm.cells, which was recovered by treatment with MMP inhibitor BB94
(Fig. 1D). These results indicate the regulation of FN assembly by
MT1-MMP.
3.2. MT1-MMP inhibition promotes FN assembly in DEX-treated
HT1080 cells
To study the mechanism by which MT1-MMP regulates FN
assembly, we employed the DEX-induced FN assembly using
HT1080 cells. HT1080 cell line, which has one activated allele of
N-ras and expresses MT1-MMP, MMP-2 and MMP-9, shows the
loss of FN assembly and the invasive phenotype [14,19,22]. Upon
stimulation with DEX, these cells reverse some aspects of the
transformed phenotype, including the decrease of cell motility
and the increase of FN synthesis [19]. HT1080 cells were cultured
with DEX and/or BB94 for 24 h. BB94 treatment inhibited MT1-
MMP-mediated MMP-2 activation and MT1-MMP autodegrada-
tion. DEX treatment induced FN synthesis, which resulted in theDMSO
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T. Takino et al. / FEBS Letters 585 (2011) 3378–3384 3381increase of DOC-soluble and -insoluble FN (Fig. 2A). Combined
treatment with DEX and BB94 induced DOC-insoluble FN more
than treatment with DEX alone. In parallel with accumulation of
DOC-soluble FN, formation of short ﬁbril was faintly observed in
the cells treated with BB94 alone, and DEX-induced FN synthesis
was observed as diffuse staining and short ﬁbril formation. FN ﬁbril
network was established, when the cells were co-treated with DEX
and BB94. MT1-MMP silencing by siRNA induced formation of
short FN ﬁbrils as BB94 did, and DEX treatment of these cells in-
duced FN matrix formation (Fig. 2B).
To conﬁrm whether the ﬁbril assembly requires FN synthesis,
HT1080 cells were transfected with siRNA for FN and treated with
DEX and BB94. FN synthesis induced by DEX was signiﬁcantly re-
duced in the cells transfected with FN siRNA, which resulted in
the loss of FN assembly (Fig. 2C). Although ectopically expressed
cFN was observed as diffuse staining, it assembled along the cellDEX - - + +
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3.3. MT1-MMP targets assembled FN
To examine whether MT1-MMP digests assembled FN, HT1080
cells were cultured with DEX and BB94 for 24 h, and then further
cultured for 12 or 24 h in the absence or presence of BB94. Cell-
associated FN was decreased in non-treated cells, which was
blocked by BB94 treatment (Fig. 3A). Concomitantly, pre-formed
FN matrix was attenuated with increasing time, which was effec-
tively suppressed by BB94 treatment (Fig. 3B). Next, FN matrix
was prepared from HT1080 cells culturing with DEX and BB94.
Then, HT1080 cells were seeded and incubated with or without
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assembled FN matrix in the presence of BB94, the cells adhered
on and extended along FN ﬁbrils. In contrast, the cells destroyed
FN matrix through the migration track and showed a motile
morphology, indicating pseudopodial extension and membrane
rufﬂing in the absence of BB94 (Fig. 3C). Similar results were
obtained with Rat 1 ﬁbroblasts-derived FN matrix (Fig. 3D).
HT1080 cells extended along FN ﬁbrils, but did not destroy them
in the presence of BB94. These results show that cell-surface
MT1-MMP degrades assembled FN, and suggest that digestion of
FN matrix by MT1-MMP regulates cell motility.
3.4. FN assembly reduces cell motility
To explore the effect of FN matrix on HT1080 cell motility, the
wound closure assay was carried out after combined treatment
with DEX and BB94. Wound closure was delayed in the cells pre-
treated with DEX and BB94 compared with non-treated cells,
which was further delayed by BB94 treatment during migration
(Fig. 4A). Although pre-formed FNmatrix was signiﬁcantly reduced
in the absence of BB94 (NT), it was still organized well in the pres-
ence of BB94, which is partially co-localized with integrin b1 and
paxillin (Fig. 4B). These results show that FN matrix formationcauses reduction of collective cell migration, and suggest the pos-
sibility that FN ﬁbrils may facilitate cell–cell adhesion, as cancer
cell-associated MT1-MMP reduces cell–cell adhesion [20]. To test
whether MT1-MMP inhibition affect cell–cell interaction through
FN assembly, HT1080 cells were cultured in suspension with or
without BB94 for 5 days. HT1080 cells formed loose spheres, which
became compact in the presence of BB94 (Fig. 4C). While FN was
detected as diffuse staining in non-treated sphere, it was deposited
as ﬁbrils at cell–cell adhesion in BB94-treated sphere. Concomi-
tantly, the level of cell-associated FN was increased by BB94 treat-
ment. These results indicate that MT1-MMP prevents FN assembly
at cell–cell adhesion, which results in the promotion of cell
dissociation.
Next, the effect of FN assembly on invasion-out of HT1080 cells
from collagen gel matrix was tested. In this experiment, HT1080
cells were embedded in collagen gel, and then cells migrating out
from collagen gel were monitored. The destruction and contraction
of embedded collagen gels and the number of migrating cells were
reduced by BB94 treatment and slightly by DEX treatment, which
was further reduced by combined treatment with BB94 and DEX
(Fig. 4D). BB94 treatment showed slight FN staining; however,
FN was assembled and deposited into collagen gel by DEX treat-
ment, which was signiﬁcantly augmented by combined treatment
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ment of HT1080 cells with DEX and BB94 induces formation of ro-
bust FN assembly and deposition, which traps cells in collagen
matrix.
4. Discussion
We have previously reported that ECM degradation by MT1-
MMP accelerates turnover of cell–matrix adhesions, resulting inpromotion of cell migration [14,21,22]. Cell–matrix adhesions de-
velop to ﬁbrillar adhesions in ﬁbroblast, which facilitates FN
assembly by creating cytoskeletal tension [1,23]. These cell–matrix
adhesions are believed to associate with directionality and velocity
of cell migration. As tumor cells can degrade a variety of ECM com-
ponents and migrate at high velocity with accelerated turnover of
cell–matrix adhesions, they frequently lack the maturation of
cell–matrix adhesions as well as FN assembly [7,8,24]. The
present study demonstrates that MT1-MMP prevents FN assembly
3384 T. Takino et al. / FEBS Letters 585 (2011) 3378–3384to facilitate tumor cell detachment, resulting in promotion of cell
motility.
FN matrix is relatively stable and its turnover under a normal
culture condition is very low. Continual FN assembly is critical
for the maintenance of FN ﬁbrils, as removal of FN or inhibition
of assembly results in rapid loss of FN matrix [3–5]. Using MDA-
MB-231 cells that express both MT1-MMP and FN, we found that
MT1-MMP knockdown induces FN matrix formation, which is
accompanied with the signiﬁcant increase of DOC-insoluble FN. Ec-
topic expression of MT1-MMP reduced FN matrix in Rat1 ﬁbro-
blasts (Fig. 1). Treatment of HT1080 cells with DEX promoted FN
synthesis, which induced short ﬁbrils but not dense matrix forma-
tion (Fig. 2). FN matrix formation by HT1080 cells is triggered by
DEX treatment and addition of soluble FN [19,25]. MT1-MMP inhi-
bition caused the increase of DOC-insoluble assembled FN matrix
but not DOC-soluble FN fraction, and ectopically expressed cFN re-
quired MT1-MMP inhibition to form ﬁbril formation in HT1080
cells (Fig. 2). In addition, cell-surface MT1-MMP digested pre-
formed FN matrix (Fig. 3). MT1-MMP may preferentially digest a
dense DOC-insoluble FN matrix and possess to accelerate turnover
of FN matrix.
MT1-MMP associated with adhesion molecules including inte-
grins, which adhered to assembled FN (Fig. 4), and thus MT1-
MMP effectively digested FN ﬁbrils (Fig. 3). MT1-MMPmay also di-
gest soluble FN, which would be incorporated into FN ﬁbrils. Alter-
natively, MT1-MMP may be implicated in FN assembly by cleaving
membrane proteins such as CD44, syndecans, and tissue transglu-
taminases, all of which associate with promotion of FN assembly.
As knocking down of MT1-MMP in MDA-MB-231 and HT1080 cells
resulted in the increase of cell-associated FN (Figs. 1 and 2), cleav-
age of FN-associated membrane proteins by MT1-MMP may regu-
late continuous binding of FN to cells that creates a high local
concentration of FN.
Cell migration is observed at intermediate adhesion levels,
which favors a balance of cell attachment and detachment to pro-
mote cell locomotion. Both extremely low and high concentration
of ECM substrates can inhibit cell motility by regulating adhesive-
ness [26,27]. We found that FN ﬁbrils reduce collective cell
migration, recruit paxillin and integrin b1 at cell–cell adhesion,
and facilitate formation of compact sphere when MT1-MMP is
inhibited (Fig. 4). The recent study has reported that cancer cell-
associated MT1-MMP reduces cell–cell adhesion, resulting in loose
sphere formation [20]. MT1-MMPmay provide tumor cells with the
ability to reduce both cell–matrix and cell–cell adhesion to
facilitate cell motility by preventing FN assembly. We do not rule
out the possibility thatMT1-MMPmay regulate strength of cell–cell
adhesion that is required for activation of integrin-bound FN to
facilitate ﬁbril assembly [6], as MT1-MMP cleaves cadherins [28].
Cleavage of collagen ﬁbrils by MT1-MMP has been reported to
be essential to promote tumor invasion into collagen gel [13].
We found that inhibition of cell invasion by DEX or BB94 is en-
hanced by their combined treatment, which is accompanied with
robust FN ﬁbril assembly and deposition into collagen gel
(Fig. 4). Thus, robust FN assembly may restrict cell motility through
the spatial limitation and/or by strengthening cellular adhesive-
ness, which is overcome by MT1-MMP.
We conclude here that MT1-MMP on tumor cell surface prefer-
entially disrupts assembled FN, which may control directionality
and velocity of cell migration by regulating not only physical space
but also cellular adhesiveness.
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